Cannabinoid receptors in human astroglial tumors

Journal of Neurochemistry

Volumn 98, Issue 3, 2006, Pages 886-893

  Held Feindt, Janka ^a   Dörner, Lutz ^a   Sahan, Gülcan ^a   Mehdorn, H Maximilian ^a   Mentlein, Rolf ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Astrocytomas; Cannabinoid receptors; Gliomas; Proliferation; Real time reverse transcriptase polymerase chain reaction; Signal transduction

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DEXANABINOL; MESSENGER RNA; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER INHIBITION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROGLIA; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, CANNABINOID;

ANIMALIA;

EID: 33745874094     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03911.x     Document Type: Article

References (22)

1. Badie B. and Schartner J. (2001) Role of microglia in glioma biology. Microsc. Res. Tech. 54, 106-113.
2. Blazquez C., Casanova M. L., Planas A., Del Pulgar T. G., Villanueva C., Fernandez-Acenero M. J., Aragones J., Huffman J. W., Jorcano J. L. and Guzman M. (2003) Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529-531.
3. Blazquez C., Gonzalez-Feria L., Alvarez L., Haro A., Casanova M. L. and Guzman M. (2004) Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res. 64, 5617-5623.
4. Carrier E. J., Kearn C. S., Barkmeier A. J., Breese N. M., Yang W., Nithipatikom K., Pfister S. L., Campbell W. B. and Hillard C. J. (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 65, 999-1007.
5. Curran N. M., Griffin B. D., O'Toole D., Brady K. J., Fitzgerald S. N. and Moynagh P. N. (2005) The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner. J. Biol. Chem. 280, 35 797-35 806.
6. Feindt J., Becker I., Blömer U., Hugo H.-H., Mehdorn H. M., Krisch B. and Mentlein R. (1995) Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J. Neurochem. 65, 1997-2005.
7. Feindt J., Schmidt A. and Mentlein R. (1998) Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells. Mol. Brain Res. 60, 228-233.
8. Galve-Roperh I., Sanchez C., Cortes M. L., del Pulgar T. G., Izquierdo M. and Guzman M. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6, 313-319.
9. Guzman M. (2003) Cannabinoids: potential anticancer agents. Nat. Rev. Cancer 3, 745-755.
10. Hart S., Fischer O. M. and Ullrich A. (2004) Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 64, 1943-1950.
11. Howlett A. C., Barth F., Bonner T. I. et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202.
12. Ludwig A., Schulte A., Schnack C., Hundhausen C., Reiss K., Brodway N., Held-Feindt J. and Mentlein R. (2005) Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J. Neurochem. 93, 1293-1303.
13. Massi P., Vaccani A., Ceruti S., Colombo A., Abbracchio M. P. and Parolaro D. (2004) Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J. Pharmacol. Exp. Ther. 308, 838-845.
14. Mentlein R., Eichler O., Forstreuter F. and Held-Feindt J. (2001) Somatostatin inhibits the production of vascular endothelial growth factor (VEGF) in glioma cells. Int. J. Cancer 92, 545-550.
15. Nunez E., Benito C., Pazos M. R., Barbachano A., Fajardo O., Gonzalez S., Tolon R. M. and Romero J. (2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53, 208-213.
16. Pufe T., Bartscher M., Petersen W., Tillmann B. and Mentlein R. (2003) Pleiotrophin, an embryonic growth and differentiation factor, is expressed in rheumatoid arthritis. Arthritis Rheumatism 48, 660-667.
17. Recht L. D., Salmonsen R., Rosetti R. et al. (2001) Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochem. Pharmacol. 62, 755-763.
18. Sanchez C., Galve-Roperh I., Canova C., Brachet P. and Guzman M. (1998) Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436, 6-10.
19. Sanchez C., de Ceballos M. L., del Pulgar T. G., Rueda D., Corbacho C., Velasco G., Galve-Roperh I., Huffman J. W., Ramon y Cajal S. and Guzman M. (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res. 61, 5784-5789.
20. Stella N. (2004) Cannabinoid signaling in glial cells. Glia 48, 267-277.
21. Vaccani A., Massi P., Colombo A., Rubino T. and Parolaro D. (2005) Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br. J. Pharmacol. 144, 1032-1036.
22. Velasco G., Galve-Roperh I., Sanchez C., Blazquez C. and Guzman M. (2004) Hypothesis: cannabinoid therapy for the treatment of gliomas? Neuropharmacology 47, 315-323.